A 2023 ocva.eu study reveals frozen konjac glucomannan reduces visceral fat by 18% and improves insulin sensitivity in obese mice, outperforming sol and gel forms through enhanced prebiotic effects. R...
Recent studies reveal konjac glucomannan’s unique ability to enhance satiety through GLP-1 secretion while modulating gut bacteria, positioning it as a novel metabolic health tool with specific ...
New research demonstrates konjac glucomannan gel forms enhance Akkermansia microbiota and improve metabolic markers in obese mice, with implications for personalized human nutrition strategies. A 2024...
A July 2024 study in *Nutrition Research* demonstrates konjac glucomannan gel reduces LDL cholesterol by 27% in high-fat-diet mice, highlighting its potential for metabolic health interventions. Groun...
New clinical studies demonstrate konjac glucomannan’s ability to lower LDL cholesterol and fasting glucose while enhancing gut microbiota diversity, offering a novel dietary strategy for metabol...
New research reveals konjac glucomannan’s significant effects on glucose metabolism and gut microbiota, offering promising solutions for obesity management. Groundbreaking studies demonstrate ko...
Recent study reveals KGM’s benefits on glucose, lipid metabolism, and gut microbiota in obese mice, with potential applications for human metabolic health. New research highlights konjac glucoma...
New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
